$12.53
-0.24-1.88%
Pre-Market: 4:37 AM EDT
Comments
Loading...
Arcturus Therapeutics Stock Guidance | NASDAQ:ARCT | Benzinga
Arcturus Therapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Arcturus Therapeutics Holdings Inc (ARCT) does not provide guidance data | ||||||||||||
FAQ
What is the most recent guidance for Arcturus Therapeutics (ARCT)?
There have been no specific sales or earnings guidance reported for Arcturus Therapeutics in recent months.
Browse guidance and forecast on all stocks.